组织标记物作为宫颈癌预后变量

Article Outline

• Abstract
• 1. Introduction
• 2. DNA ploidy
• 3. Cell-cycle and apoptosis-regulatory proteins
  • 3.1. INK4 family proteins, Cip-Kip family proteins, and cyclins
  • 3.2. p53 and p73
  • 3.3. Inhibitors of apoptosis
• 4. Epidermal growth factor receptor [EGFR] family
• 5. Vascular endothelial growth factor [VEGF]
• 6. Cyclooxygenase [COX]-2
• 7. Other proteins
• 8. HPV status
• 9. Tumor hypoxia
• 10. Tumor infiltrating lymphocytes [TIL]
• 11. Loss of heterozygosity
• 12. Microarray technology and microRNA (miRNA)
• 13. Conclusions
• Conflict of interest statement
• Reviewe
  
  

  上一篇： 矩阵辅助激光解吸附/离子化，基于时间飞跃质谱血液组基因分型——备选方法

  下一篇： 骨髓及外骨髓增殖新生物分子诊断： JAK2 V617F和相关突变检测英国指导原则

  学科代码：肿瘤学　　　关键词：Cervical carcinoma DNA content p53 protein Epidermal growth factor recept Vascular endothelial growth fa Cyclooxygenase-2 Tumor hypoxia Tumor infiltrating lymphocytes
  来源： Critical Reviews In Oncology Hematology
  顶一下（0）